pharma · Osteoarthritis of the Knee · Multiple Sclerosis · APUS
Apimeds Pharmaceuticals US
Apimeds Pharmaceuticals US is a pharma organization headquartered in Matawan, USA. It trades on NYSE under ticker APUS. Primary therapeutic focus areas include Osteoarthritis of the Knee, Multiple Sclerosis. NovaPharmaNe
Matawan, USA HQ
2020 Founded
3 Employees
Public company Type
APUS · NYSE Ticker
Company details
- Status
- Public
- HQ
- Matawan, USA
- Founded
- 2020
- Employees
- 3
- Programs
- 3
- Drugs
- 2
- Patents
- 0
01-13
Phase 3 · mab · Osteoarthritis of the Knee
01-13 for Osteoarthritis of the Knee is a Phase 3 program (mab) at Apimeds Pharmaceuticals US with 1 ClinicalTrials.gov record(s).
Internal code 01-13
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Apimeds Pharmaceuticals US
- Phase
- Phase 3
- Modality
- mab
- Indication
- Osteoarthritis of the Knee
- Status
- completed
- Trials
- 1